Cholinergic mediation of growth hormone secretion induced by thyrotropin-releasing hormone in cirrhotic patients

Acta Endocrinol (Copenh). 1987 Apr;114(4):603-8. doi: 10.1530/acta.0.1140603.

Abstract

In order to evaluate the possible involvement of muscarinic cholinergic receptors in the GH response to TRH in patients with liver cirrhosis, 8 males with post-hepatitic cirrhosis and 11 males with post-alcoholic cirrhosis were primed with the anticholinergic agent pirenzepine and tested with TRH. In addition, 10 male patients affected by piecemeal necrosis were tested in a similar manner. High basal concentrations of GH were found in all groups. None of the patients with piecemeal necrosis responded to TRH, whereas in patients with post-hepatitic and in post-alcoholic cirrhosis, TRH induced a significant rise in GH levels. The priming with pirenzepine (40 mg given iv 10 min before TRH) completely blocked the TRH-induced GH increase, but did not affect the TRH-induced TSH release. These data suggest that a muscarinic cholinergic pathway is involved in the anomalous response of GH to TRH in patients with liver cirrhosis. The lack of effect of pirenzepine on the TRH-stimulated TSH release suggests that the muscarinic cholinergic mediation is peculiar for the effect of TRH on GH secretion.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Growth Hormone / blood
  • Growth Hormone / metabolism*
  • Humans
  • Liver / metabolism
  • Liver / pathology
  • Liver Cirrhosis / blood*
  • Liver Cirrhosis, Alcoholic / blood*
  • Male
  • Middle Aged
  • Necrosis
  • Pirenzepine / pharmacology
  • Receptors, Muscarinic / metabolism*
  • Thyrotropin-Releasing Hormone*

Substances

  • Receptors, Muscarinic
  • Pirenzepine
  • Thyrotropin-Releasing Hormone
  • Growth Hormone